[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Soligenix Inc (SNGX)

Soligenix Inc (SNGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,556
  • Shares Outstanding, K 10,306
  • Annual Sales, $ 0 K
  • Annual Income, $ -11,080 K
  • EBIT $ -12 M
  • EBITDA $ -12 M
  • 60-Month Beta 1.32
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.66
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.46
  • Most Recent Earnings $-0.58 on 11/07/25
  • Next Earnings Date 05/08/26 [--]
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3157 +9.28%
on 04/30/26
1.4300 -75.87%
on 04/27/26
-0.8050 (-70.00%)
since 04/01/26
3-Month
0.3157 +9.28%
on 04/30/26
1.4300 -75.87%
on 04/27/26
-0.9050 (-72.40%)
since 01/30/26
52-Week
0.3157 +9.28%
on 04/30/26
6.2299 -94.46%
on 08/18/25
-1.5750 (-82.03%)
since 05/01/25

Most Recent Stories

More News
Soligenix Announces Interim Results from the Phase 3 FLASH2 Trial Evaluating HyBryteâ„¢ in Treatment of Cutaneous T-Cell Lymphoma

PRINCETON, N.J. , April 28, 2026 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products...

SNGX : 0.3450 (unch)
Soligenix (NASDAQ: SNGX) Highlights Patient-Centric Drug Development Strategy Through Reformulation Approach

By Christopher J. Schaber, chairman, president, and CEO, Soligenix; published via Clinical Leader

SNGX : 0.3450 (unch)
Soligenix (NASDAQ: SNGX) Strengthens Pipeline as European Commission Grants SGX945 Orphan Status

Recognition from global regulatory authorities can serve as a powerful validation of a therapy’s potential, particularly in the rare disease space where development challenges are significant and patient...

SNGX : 0.3450 (unch)
Soligenix (NASDAQ: SNGX) Advances CTCL Research with Interim Analysis, Comparative Study Results

Advancing clinical research while generating positive data is a critical combination in biotechnology, particularly when addressing diseases with limited treatment options. Soligenix (NASDAQ: SNGX) is...

SNGX : 0.3450 (unch)
Soligenix (NASDAQ: SNGX) Showcased for Smarter Path to Drug Development

Soligenix (NASDAQ: SNGX) was featured in a recent article that discussed its positioning in a landscape where modern biopharmaceutical innovation often revolves around a powerful idea: One scientific mechanism...

SNGX : 0.3450 (unch)
BIO-key International, 20/20 Biolabs, Society Pass, and Soligenix Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

ORLANDO, FL / ACCESS Newswire / April 10, 2026 / RedChip Companies will air interviews with BIO-key International, Inc. (Nasdaq:BKYI), 20/20 Biolabs, Inc. (Nasdaq:AIDX), Society Pass Inc. (Nasdaq:SOPA),...

AIDX : 1.5450 (-2.83%)
BKYI : 5.33 (+6.81%)
SNGX : 0.3450 (unch)
SOPA : 0.4070 (+4.90%)
Soligenix (NASDAQ: SNGX) Publishes Positive HyBryte Study Results In Oncology and Therapy

Soligenix (NASDAQ: SNGX) announced the publication of positive results from its comparability study evaluating HyBryte(TM) versus Valchlor(R) for the treatment of cutaneous T-cell lymphoma in Oncology...

SNGX : 0.3450 (unch)
Positive Clinical Results from HyBryte™ Comparative Study Evaluating HyBryte™ Against Valchlor® in the Treatment of Cutaneous T-Cell Lymphoma Published in Oncology and Therapy

HyBryte™ demonstrates more rapid and robust treatment response compared to Valchlor ® during 12-week treatment course

SNGX : 0.3450 (unch)
Soligenix (NASDAQ: SNGX) Highlights Phase 3 CTCL Progress and Orphan Drug Milestones in 2025 Results

Soligenix (NASDAQ: SNGX) reported 2025 results highlighting progress across its rare disease pipeline, including advancing its Phase 3 FLASH2 trial of HyBryte(TM) for cutaneous T-cell lymphoma with interim...

SNGX : 0.3450 (unch)
Soligenix Announces Recent Accomplishments and Year End 2025 Financial Results

Upcoming high-impact milestones include interim analysis in Q2 2026 and top-line results in H2 2026 from HyBryteâ„¢ trial

SNGX : 0.3450 (unch)

Business Summary

Soligenix, Inc. is a late-stage biopharmaceutical company focused on developing products to treat the life-threatening side effects of cancer treatments and serious gastrointestinal diseases where, as well as developing several biodefense vaccines and therapeutics. The Company operates in two reportable...

See More

Key Turning Points

3rd Resistance Point 0.3807
2nd Resistance Point 0.3703
1st Resistance Point 0.3576
Last Price 0.3450
1st Support Level 0.3345
2nd Support Level 0.3241
3rd Support Level 0.3114

See More

52-Week High 6.2299
Fibonacci 61.8% 3.9707
Fibonacci 50% 3.2728
Fibonacci 38.2% 2.5749
Last Price 0.3450
52-Week Low 0.3157

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.